By: admin - - September 12, 2019
Las Vegas, Nevada (September 12, 2019) – JanOne (NASDAQ: JAN), a newly launched initiative with the focused intent of offering innovative, actionable solutions to end the opioid crisis, is proud to name host of America This Week and financial commentator Eric Bolling as its President and Chairman.
As one personally affected by the opioid scourge, Bolling has dedicated himself to fighting the opioid epidemic by executing the mission of JanOne: To develop, among other things, revolutionary pain medications designed to replace today’s highly addictive and often fatal opioids.
“I am elated to become part of JanOne and to help fulfill the mission of developing alternative, non-opioid pain drugs,” Bolling said. “I’m drawn into this challenge—and passionately dedicated to it—by my determination not to see another father bury a child, as I have done. JanOne plans to bring to market a much-needed, non-opioid and non-addictive pain drug to meet the demands of an $60 billion a year market.”
“Once our goals are achieved, doctors worldwide will be able to safely prescribe pain medications without the risks we see with the drugs of today. We are hoping this will lead to significant declines in people who get addicted and a significant fall in deaths.”
Bolling explained that the company “is currently in discussion with several potential partners, including universities and various corporations, regarding development and marketing of non-opioid pain drugs.” He added, “Our goal is to develop medications that kill pain, not people.”
After a successful career as a commodities trader, Bolling moved into media as a rising television personality. He helped to develop CNBC’s Fast Money, hosted Fox Business Channel’s Cashin’ In, and was co-host of The Five and of Fox News Specialists. His New York Times best seller Wake Up America came out in 2016. Today, in addition to his executive leadership of JanOne, Eric remains engaged in political and social issues as host of America This Week on Blaze TV.
These accomplishments are backdrop to Bolling’s passion for tacking the opioid crisis. On a terrible night in 2017, he and his wife Adrienne learned by phone that their only son, Eric Chase, a University of Colorado sophomore, had fallen victim to a Xanax tablet laced with the deadly opioid fentanyl. That call destroyed a family’s happiness—but also kindled a craving to extract meaning from personal grief. As a tribute to his son, Bolling established The Eric Chase Foundation to educate the world about the opioid crisis and to lobby for preventive and treatment measures. His personal commitment to ending the crisis motivates his taking on executive responsibilities at JanOne, which was founded to develop non-opioid pain medications.
JanOne (NASDAQ: JAN) is a publicly listed company positioned to combat the opioid crisis by developing revolutionary, non-addictive and non-opioid painkillers. Targeting opioids brings significant business opportunities—including management’s intention to achieve higher shareholder value—while it draws private-sector resources into an urgent public health crisis. The company continues to manage its legacy businesses under their existing brand names.
JanOne sees every day as an opportunity for fresh ideas to end the opioid epidemic, the worst drug crisis in our nation’s history.
As a NASDAQ-listed company, JanOne draws private-sector resources into this urgent fight. We seek innovative treatments—focusing on developing revolutionary, non-addictive drugs that kill pain, not people.
February 6, 2020
January 28, 2020
January 23, 2020
March is National Autoimmune Disease month and as we are fighting an “invisible epidemic”, it is a great time to bring awareness. Approximately 23.5 million Americans are affected across the country, according to the NIH.
Best wishes of good health and safety in the days and weeks ahead to all of followers, friends and family.